Douglas J. Manion

1.5k citations
10 papers · 1.0k indexed · 1 hit paper · h-index 8
Topics
HIV Research and Treatment (7 papers)HIV/AIDS drug development and treatment (7 papers)HIV/AIDS Research and Interventions (4 papers)

In The Last Decade

Douglas J. Manion

10 papers receiving 961 citations

Hit Papers

Efavirenz plus Zidovudine and Lamivudine, Efavirenz plus ...19992026200820171999250500750

Peers

Douglas J. Manion
Comparison fields: 5 of 67
  • Infectious Diseases 898
  • Virology 770
  • Epidemiology 165
  • Emergency Medicine 164
  • Molecular Biology 62
Replace Nancy Ruíz with:
Nancy Ruíz United States
Catherine Knupp United States
Miguel Goicoechea United States
Lucinda R. Gilde United States
Gordon Crofoot United States
Nanci Hawley‐Foss Canada
Mark Becker United States
James Stanford United States
Irina Magdalena Dumitru Romania
Richard Stryker United States
Douglas J. Manion relative to Nancy Ruíz United States Nancy Ruíz's profile →
Citations per field
00.5×1.5×
Nancy Ruíz · 1×
Citations per year

Countries citing papers authored by Douglas J. Manion

Since Specialization
Citations

This map shows the geographic impact of Douglas J. Manion's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas J. Manion with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas J. Manion more than expected).

Fields of papers citing papers by Douglas J. Manion

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Douglas J. Manion. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas J. Manion. The network helps show where Douglas J. Manion may publish in the future.

Co-authorship network of co-authors of Douglas J. Manion

This figure shows the co-authorship network connecting the top 25 collaborators of Douglas J. Manion. A scholar is included among the top collaborators of Douglas J. Manion based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Douglas J. Manion. Douglas J. Manion is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
#WorkIndexed citations
1 39
2 27
3 65
4
Efavirenz plus Zidovudine and Lamivudine, Efavirenz plus Indinavir, and Indinavir plus Zidovudine and Lamivudine in the Treatment of HIV-1 Infection in Adultsbreakdown →
788
5 10
6 27
7
Susceptibility of human cytomegalovirus to two-drug combinations in vitro.
18
8 7
9 2
10 31

About Douglas J. Manion

Douglas J. Manion is a scholar working on Virology, Infectious Diseases and Parasitology, having authored 10 papers that have together received 1.0k indexed citations. Recurring topics across this work include HIV Research and Treatment (7 papers), HIV/AIDS drug development and treatment (7 papers) and HIV/AIDS Research and Interventions (4 papers). The work is most often cited by research in Virology (770 citations), Infectious Diseases (898 citations) and Emergency Medicine (164 citations). Douglas J. Manion has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include Dominic Labriola, Nancy Ruíz, Javier O Morales-Ramirez, Richard Stryker, Daniel J. Skiest, James Stanford, Philip C. Johnson, Schlomo Staszewski, Anita Rachlis and Karen T. Tashima. Their work appears in journals such as New England Journal of Medicine, Gastroenterology and Clinical Infectious Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026